Wolfgang Peter Fendler
Author Correction: Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma.
Váraljai R, Zimmer L, Al-Matary Y, Kaptein P, Albrecht L, Shannan B, Brase J, Gusenleitner D, Amaral T, Wyss N, Utikal J, Flatz L, Rambow F, Reinhardt H, Dick J, Engel D, Horn S, Ugurel S, Sondermann W, Livingstone E, Sucker A, Paschen A, Zhao F, Placke J, Klose J, Fendler W, Thommen D, Helfrich I, Schadendorf D, Roesch A. Author Correction: Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma. Nat Cancer 2023; 4:1395.
01.09.2023Author Correction: Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma.
01.09.2023Nat Cancer 2023; 4:1395
Váraljai Renáta, Zimmer Lisa, Al-Matary Yahya, Kaptein Paulien, Albrecht Lea J, Shannan Batool, Brase Jan C, Gusenleitner Daniel, Amaral Teresa, Wyss Nina, Utikal Jochen, Flatz Lukas, Rambow Florian, Reinhardt Hans Christian, Dick Jenny, Engel Daniel R, Horn Susanne, Ugurel Selma, Sondermann Wiebke, Livingstone Elisabeth, Sucker Antje, Paschen Annette, Zhao Fang, Placke Jan M, Klose Jasmin M, Fendler Wolfgang Peter, Thommen Daniela S, Helfrich Iris, Schadendorf Dirk, Roesch Alexander
Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma.
Váraljai R, Zimmer L, Al-Matary Y, Kaptein P, Albrecht L, Shannan B, Brase J, Gusenleitner D, Amaral T, Wyss N, Utikal J, Flatz L, Rambow F, Reinhardt H, Dick J, Engel D, Horn S, Ugurel S, Sondermann W, Livingstone E, Sucker A, Paschen A, Zhao F, Placke J, Klose J, Fendler W, Thommen D, Helfrich I, Schadendorf D, Roesch A. Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma. Nat Cancer 2023; 4:1292-1308.
31.07.2023Interleukin 17 signaling supports clinical benefit of dual CTLA-4 and PD-1 checkpoint inhibition in melanoma.
31.07.2023Nat Cancer 2023; 4:1292-1308
Váraljai Renáta, Zimmer Lisa, Al-Matary Yahya, Kaptein Paulien, Albrecht Lea J, Shannan Batool, Brase Jan C, Gusenleitner Daniel, Amaral Teresa, Wyss Nina, Utikal Jochen, Flatz Lukas, Rambow Florian, Reinhardt Hans Christian, Dick Jenny, Engel Daniel R, Horn Susanne, Ugurel Selma, Sondermann Wiebke, Livingstone Elisabeth, Sucker Antje, Paschen Annette, Zhao Fang, Placke Jan M, Klose Jasmin M, Fendler Wolfgang Peter, Thommen Daniela S, Helfrich Iris, Schadendorf Dirk, Roesch Alexander
Joint EANM/SNMMI procedure guideline for the use of Lu-labeled PSMA-targeted radioligand-therapy (Lu-PSMA-RLT).
Kratochwil C, Fendler W, Eiber M, Hofman M, Emmett L, Calais J, Osborne J, Iravani A, Koo P, Lindenberg L, Baum R, Bozkurt M, Delgado Bolton R, Ezziddin S, Forrer F, Hicks R, Hope T, Kabasakal L, Konijnenberg M, Kopka K, Lassmann M, Mottaghy F, Oyen W, Rahbar K, Schöder H, Virgolini I, Bodei L, Fanti S, Haberkorn U, Hermann K. Joint EANM/SNMMI procedure guideline for the use of Lu-labeled PSMA-targeted radioligand-therapy (Lu-PSMA-RLT). Eur J Nucl Med Mol Imaging 2023; 50:2830-2845.
29.05.2023Joint EANM/SNMMI procedure guideline for the use of Lu-labeled PSMA-targeted radioligand-therapy (Lu-PSMA-RLT).
29.05.2023Eur J Nucl Med Mol Imaging 2023; 50:2830-2845
Kratochwil Clemens, Fendler Wolfgang Peter, Eiber Matthias, Hofman Michael S, Emmett Louise, Calais Jeremie, Osborne Joseph R, Iravani Amir, Koo Phillip, Lindenberg Liza, Baum Richard, Bozkurt Murat Fani, Delgado Bolton Roberto C, Ezziddin Samer, Forrer Flavio, Hicks Rodney J, Hope Thomas A, Kabasakal Levent, Konijnenberg Mark, Kopka Klaus, Lassmann Michael, Mottaghy Felix M, Oyen Wim J G, Rahbar Kambiz, Schöder Heiko, Virgolini Irene, Bodei Lisa, Fanti Stefano, Haberkorn Uwe, Hermann Ken
EANM procedure guidelines for radionuclide therapy with Lu-labelled PSMA-ligands (Lu-PSMA-RLT)
Kratochwil C, Lassmann M, Mottaghy F, Oyen W, Rahbar K, Schöder H, Virgolini I, Wester H, Bodei L, Fanti S, Haberkorn U, Kopka K, Konijnenberg M, Kabasakal L, Fendler W, Eiber M, Baum R, Bozkurt M, Czernin J, Delgado Bolton R, Ezziddin S, Forrer F, Hicks R, Hope T, Herrmann K. EANM procedure guidelines for radionuclide therapy with Lu-labelled PSMA-ligands (Lu-PSMA-RLT). Eur J Nucl Med Mol Imaging 2019; 46:2536-2544.
22.08.2019EANM procedure guidelines for radionuclide therapy with Lu-labelled PSMA-ligands (Lu-PSMA-RLT)
22.08.2019Eur J Nucl Med Mol Imaging 2019; 46:2536-2544
Kratochwil Clemens, Lassmann Michael, Mottaghy Felix M, Oyen Wim, Rahbar Kambiz, Schöder Heiko, Virgolini Irene, Wester Hans-Jürgen, Bodei Lisa, Fanti Stefano, Haberkorn Uwe, Kopka Klaus, Konijnenberg Mark, Kabasakal Levant, Fendler Wolfgang Peter, Eiber Matthias, Baum Richard, Bozkurt Murat Fani, Czernin Johannes, Delgado Bolton Roberto C, Ezziddin Samer, Forrer Flavio, Hicks Rodney J, Hope Thomas A, Herrmann Ken